跳至主要内容
临床试验/NCT00584753
NCT00584753终止1 期

Molecular Imaging of Breast Cancer With Breast PET/CT

University of California, Davis2 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2007年4月最近更新:
适应症

试验速览

阶段
1 期
状态
终止
入组人数
4
试验地点
2
主要终点
End-points of this study are whether women will accept the imaging position and timing, and whether functional properties of breast cancer can be imaged with this device.

研究概览

简要总结

This study is a feasibility study to determine if a combined breast PET/CT scanner can image malignant functional activity while determining anatomical structure in the same clinical setting for patients with breast cancer. End-points of this study are whether women will accept the imaging position and timing, and whether functional properties of breast cancer can be imaged with this device. The secondary purpose of this study is to explore protocol parameters with a view to optimizing imaging performance whilst minimizing patient discomfort. Imaging results will be compared to histological samples to determine ground truth.

详细描述

PET is literally a molecular imaging modality. In monitoring the patient's response to a specific chemotherapeutic regime, baseline and subsequent PET/CT scans can be used to quantitatively determine the therapeutic effect of the regime, using the standard uptake value (SUV), a common metric in PET imaging. The breast PET/CT system will facilitate molecular imaging of breast cancer using a number of radiolabeled molecules, available both commercially (18-FDG) and from the research environment.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Normal Adult Volunteers
  • Female, at least 18 years of age
  • Ability to lie motionless for up to 20 minutes
  • Patient Volunteers
  • Female, at least 18 years of age
  • Diagnostic findings from prior mammography highly suggestive of invasive breast carcinoma (BI-RADS category 5)
  • Not pregnant or breast-feeding
  • Ability to lie motionless for up to 20 minutes

排除标准

  • Normal Adult Volunteers
  • Inability to understand the risks and benefits of the study
  • Patient Volunteers
  • Recent breast biopsy
  • Diagnostic findings from prior mammography highly suggestive of noninvasive ductal or lobular carcinoma
  • Uncontrolled diabetes
  • Diabetic and blood sugar level > 200 mg/dL
  • Positive urine pregnancy test or currently breast-feeding
  • Inability to understand the risks and benefits of the study

结局指标

主要结局

End-points of this study are whether women will accept the imaging position and timing, and whether functional properties of breast cancer can be imaged with this device.

时间窗: 5 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ramsey Badawi, Ph.D

Associate Professor

University of California, Davis

研究点 (2)

Loading locations...

相似试验